The time course of the pO2 in tumors after radiation and various doses of cyclophosphamide will be measured as a measure of reoxygenation. These have already suggested, in mouse models optimal dose timing to maximize tumoricidal effect; the optimization of combined drug and radiation timing according to the time of maximum reoxygenation is hypothesized and will be verified using the implantable EPR substrate.
Showing the most recent 10 out of 44 publications